Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07166848 · ClinicalTrials.gov registry record · NA

Electrostimulation Study for Ocular Graft vs. Host Disease

A NA study of Chronic Ocular Graft-versus-host Disease, sponsored by Zhonghui K. Luo, MD, PhD.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT07166848: Recruiting NA study of Chronic Ocular Graft-versus-host Disease, sponsored by Zhonghui K. Luo, MD, PhD.

NCT07166848 is a NA study of Chronic Ocular Graft-versus-host Disease that is actively recruiting participants, run by Zhonghui K. Luo, MD, PhD. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07166848, a NA study of Chronic Ocular Graft-versus-host Disease, is actively recruiting participants, sponsored by Zhonghui K. Luo, MD, PhD.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Interventions

  • DEVICE Electrodes with Currents
  • DEVICE Electrodes without Currents

Study Locations (1)

Massachusetts

  • Massachusetts Eye and Ear - Longwood Campus - Boston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-11-30
Est. Completion 2029-11-30
Phase NA
Zhonghui K. Luo, MD, PhD

1 total trials

What NCT07166848 shows while recruiting

NCT07166848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Chronic Ocular Graft-versus-host Disease appearing as the primary indexed condition, and to 2 interventions - of which Electrodes with Currents is the first listed.

NCT07166848 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07166848 about?

NCT07166848 is a clinical study titled "Electrostimulation Study for Ocular Graft vs. Host Disease". This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

What is the current status of trial NCT07166848?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-11-30. Estimated completion is 2029-11-30.

What conditions does trial NCT07166848 study?

This clinical trial studies the following conditions: Chronic Ocular Graft-versus-host Disease.

What interventions are being tested in trial NCT07166848?

The interventions under investigation include: Electrodes with Currents (DEVICE), Electrodes without Currents (DEVICE).

Who is sponsoring clinical trial NCT07166848?

This trial is sponsored by Zhonghui K. Luo, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07166848 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Ocular Graft-versus-host Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07166848's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07166848, the US trial registry maintained by the National Library of Medicine. NCT07166848 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.